Pages that link to "Q53332426"
Jump to navigation
Jump to search
The following pages link to Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. (Q53332426):
Displaying 50 items.
- Mechanical stretch up-regulates microRNA-26a and induces human airway smooth muscle hypertrophy by suppressing glycogen synthase kinase-3β (Q24610983) (← links)
- miRNAs in human cancer (Q24628889) (← links)
- The role of miR-26 in tumors and normal tissues (Review) (Q24629056) (← links)
- MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer (Q24632636) (← links)
- Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model (Q24655262) (← links)
- UCbase & miRfunc: a database of ultraconserved sequences and microRNA function (Q24656355) (← links)
- Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype (Q24658407) (← links)
- The Role of miRNA in Papillary Thyroid Cancer in the Context of miRNA Let-7 Family (Q26744496) (← links)
- Appraising MicroRNA-155 as a Noninvasive Diagnostic Biomarker for Cancer Detection: A Meta-Analysis (Q26772056) (← links)
- MECHANISMS IN ENDOCRINOLOGY: MicroRNA in diagnostics and therapy of thyroid cancer (Q26778767) (← links)
- MicroRNA Processing and Human Cancer (Q26797308) (← links)
- High mobility group a proteins as tumor markers (Q26853205) (← links)
- Circulating microRNAs in cancer: origin, function and application (Q27013716) (← links)
- Deletion of the RNaseIII enzyme dicer in thyroid follicular cells causes hypothyroidism with signs of neoplastic alterations (Q27310195) (← links)
- miRNA expression and function in thyroid carcinomas: a comparative and critical analysis and a model for other cancers (Q28078451) (← links)
- MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1 (Q28256145) (← links)
- Circulating MiR-125b as a marker predicting chemoresistance in breast cancer (Q28482362) (← links)
- A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis (Q30540674) (← links)
- MicroRNA expression and identification of putative miRNA targets in ovarian cancer (Q33344505) (← links)
- Noncoding RNAs in endocrine malignancy (Q33577889) (← links)
- Identification of senescence-associated circular RNAs (SAC-RNAs) reveals senescence suppressor CircPVT1 (Q33580276) (← links)
- Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours (Q33630865) (← links)
- Thyroglobulin increases thyroid cell proliferation via the suppression of specific microRNAs. (Q33632207) (← links)
- Identification of microRNAs that mediate thyroid cell growth induced by TSH (Q33636620) (← links)
- MicroRNA expression variability in human cervical tissues (Q33644448) (← links)
- MiR-20a is upregulated in anaplastic thyroid cancer and targets LIMK1. (Q33654795) (← links)
- Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies (Q33691759) (← links)
- Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions (Q33732120) (← links)
- microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma (Q33893064) (← links)
- Cancer models in Caenorhabditis elegans (Q33903791) (← links)
- Anaplastic Thyroid Carcinoma: Current Treatments and Potential New Therapeutic Options with Emphasis on TfR1/CD71. (Q33914771) (← links)
- MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. (Q33967256) (← links)
- Differential expression analysis of balding and nonbalding dermal papilla microRNAs in male pattern baldness with a microRNA amplification profiling method. (Q34038621) (← links)
- Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis (Q34089030) (← links)
- MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology (Q34119098) (← links)
- Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells (Q34181700) (← links)
- The clinical potential of microRNAs (Q34220723) (← links)
- miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression (Q34248579) (← links)
- MicroRNAs in human cancer (Q34325959) (← links)
- MIR141 Expression Differentiates Hashimoto Thyroiditis from PTC and Benign Thyrocytes in Irish Archival Thyroid Tissues. (Q34411905) (← links)
- Retracted: MiR-30a-5p Antisense Oligonucleotide Suppresses Glioma Cell Growth by Targeting SEPT7 (Q34575936) (← links)
- Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study. (Q34621889) (← links)
- Gene expression of vitamin D metabolic enzymes at baseline and in response to vitamin D treatment in thyroid cancer cell lines. (Q34701596) (← links)
- MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility (Q34749465) (← links)
- miR-22 represses cancer progression by inducing cellular senescence (Q34825182) (← links)
- Retracted: miR-26a and its Target CKS2 Modulate Cell Growth and Tumorigenesis of Papillary Thyroid Carcinoma (Q34825705) (← links)
- Differences in microRNA expression during tumor development in the transition and peripheral zones of the prostate. (Q34868706) (← links)
- Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk (Q34920257) (← links)
- ERManI is a target of miR-125b and promotes transformation phenotypes in hepatocellular carcinoma (HCC) (Q34938492) (← links)
- Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway (Q34955965) (← links)